The incorporation of Injection Depot MedroxyProgesterone Acetate - Subcutaneous (DMPA-SC) as a self-care contraceptive option into India’s national Family Planning Programme represents a promising and well-timed timely opportunity. Presently, the available self-care contraceptive options include condoms and oral contraceptive pills as regular contraceptive methods, along with emergency contraceptive pills as an on-demand option.
Introducing DMPA SC as a self-administered method can play a crucial role in addressing the unmet need for contraception among women particularly those from vulnerable communities who encounter numerous barriers to accessing contraceptives. This would mark a significant milestone in supporting both couples and individuals in realizing their reproductive intentions, while also ensuring access to the furthest reaches of the population.
Adding DMPA-SC, to the basket of self-care options will empower women with greater contraceptive choices and autonomy to fulfill their fertility goals.
